Hepatic fibrosis/cirrhosis is a significant health burden worldwide, resulting in liver failure or
hepatocellular carcinoma (HCC) and accounting for many deaths each year. The …

Liver cirrhosis is the final pathological result of various chronic liver diseases, and fibrosis is
the precursor of cirrhosis. Many types of cells, cytokines and miRNAs are involved in the …

The human umbilical cord is a promising source of mesenchymal stem cells (HUCMSCs).
Unlike bone marrow stem cells, HUCMSCs have a painless collection procedure and faster …

Mesenchymal stem cells (MSCs) have been considered as an attractive tool for the therapy
of diseases. Exosomes excreted from MSCs can reduce myocardial ischemia/reperfusion …

Acute-on-chronic liver failure (ACLF) is a severe, life-threatening complication, and new and
efficient therapeutic strategies for liver failure are urgently needed. Mesenchymal stem cell …

Decompensated liver cirrhosis (LC), a life‐threatening complication of chronic liver disease,
is one of the major indications for liver transplantation. Recently, mesenchymal stem cell …

Mesenchymal stromal cells (MSCs) are widely used in the clinic because they involve fewer
ethical issues and safety concerns compared to other stem cells such as embryonic stem …

Mesenchymal stem cells (MSCs) are stromal cells that have the ability to self‐renew and
also exhibit multilineage differentiation into both mesenchymal and nonmesenchymal …

Liver disease is a major health problem that endangers human health worldwide. Currently,
whole organ allograft transplantation is the gold standard for the treatment of end-stage liver …

Hepatocyte transplantation has shown potential as an additional treatment modality for
certain diseases of the liver. To date, patients with liver-based metabolic disorders or acute …